MedKoo Cat#: 406567 | Name: WH-4-023
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

WH-4-023 is a potent and selective dual Lck/Src inhibitor with IC50 of 2 nM/6 nM for Lck and Src kinase respectively. The lymphocyte-specific kinase ( Lck ) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and NK cells. Genetic evidence in both mice and humans demonstrates that Lck kinase activity is critical for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation.

Chemical Structure

WH-4-023
WH-4-023
CAS#837422-57-8

Theoretical Analysis

MedKoo Cat#: 406567

Name: WH-4-023

CAS#: 837422-57-8

Chemical Formula: C32H36N6O4

Exact Mass: 568.2798

Molecular Weight: 568.67

Elemental Analysis: C, 67.59; H, 6.38; N, 14.78; O, 11.25

Price and Availability

Size Price Availability Quantity
10mg USD 90.00 Ready to ship
25mg USD 150.00 Ready to ship
50mg USD 250.00 Ready to ship
100mg USD 450.00 Ready to ship
200mg USD 850.00 Ready to ship
500mg USD 1,650.00 Ready to ship
1g USD 2,650.00 Ready to ship
2g USD 4,650.00 Ready to ship
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
WH-4-023; WH4-023; WH 4-023; WH-4023; WH 4023; WH4023;
IUPAC/Chemical Name
2,6-dimethylphenyl (2,4-dimethoxyphenyl)(2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)carbamate
InChi Key
NBTNHSGBRGTFJS-UHFFFAOYSA-N
InChi Code
InChI=1S/C32H36N6O4/c1-22-7-6-8-23(2)30(22)42-32(39)38(27-14-13-26(40-4)21-28(27)41-5)29-15-16-33-31(35-29)34-24-9-11-25(12-10-24)37-19-17-36(3)18-20-37/h6-16,21H,17-20H2,1-5H3,(H,33,34,35)
SMILES Code
O=C(OC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3
Appearance
Off-white solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
        

Preparing Stock Solutions

The following data is based on the product molecular weight 568.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Guo A, Zhong P, Wang L, Lin X, Feng M. Prognosis and immunotherapeutic implications of molecular classification of cervical cancer based on immunophenoscore-related genes. J Biomol Struct Dyn. 2024 Sep 23:1-16. doi: 10.1080/07391102.2024.2404545. Epub ahead of print. PMID: 39308337. 2: Choi H, Oh D, Kim M, Jawad A, Zheng H, Cai L, Lee J, Kim E, Lee G, Jang H, Moon C, Hyun SH. Establishment of porcine embryonic stem cells in simplified serum free media and feeder free expansion. Stem Cell Res Ther. 2024 Aug 7;15(1):245. doi: 10.1186/s13287-024-03858-2. PMID: 39113095; PMCID: PMC11304784. 3: Li H, Li F, Wang BS, Zhu BL. Prognostic significance of exportin-5 in hepatocellular carcinoma. World J Gastrointest Oncol. 2024 Jul 15;16(7):3069-3081. doi: 10.4251/wjgo.v16.i7.3069. PMID: 39072169; PMCID: PMC11271777. 4: Li G, Ping M, Guo J, Wang J. Comprehensive analysis of CPNE1 predicts prognosis and drug resistance in gastric adenocarcinoma. Am J Transl Res. 2024 Jun 15;16(6):2233-2247. doi: 10.62347/NIYR2094. PMID: 39006290; PMCID: PMC11236623. 5: Huang H, Li Q, Tu X, Yu D, Zhou Y, Ma L, Wei K, Gao Y, Zhao G, Han R, Ye F, Ke C. DNA hypomethylation patterns and their impact on the tumor microenvironment in colorectal cancer. Cell Oncol (Dordr). 2024 Aug;47(4):1375-1389. doi: 10.1007/s13402-024-00933-x. Epub 2024 Mar 23. PMID: 38520647. 6: Nelson AR, Christiansen SL, Naegle KM, Saucerman JJ. Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts. Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2303513121. doi: 10.1073/pnas.2303513121. Epub 2024 Jan 24. PMID: 38266046; PMCID: PMC10835125. 7: Nelson AR, Christiansen SL, Naegle KM, Saucerman JJ. Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts. bioRxiv [Preprint]. 2023 Oct 23:2023.03.01.530599. doi: 10.1101/2023.03.01.530599. Update in: Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2303513121. doi: 10.1073/pnas.2303513121. PMID: 36909540; PMCID: PMC10002757. 8: Wang X, Xie C, Lin L. Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma. J Bone Oncol. 2022 Dec 9;38:100463. doi: 10.1016/j.jbo.2022.100463. PMID: 36569351; PMCID: PMC9772846. 9: Kafita D, Daka V, Nkhoma P, Zulu M, Zulu E, Tembo R, Ngwira Z, Mwaba F, Sinkala M, Munsaka S. High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs. PLoS One. 2021 Apr 9;16(4):e0248984. doi: 10.1371/journal.pone.0248984. PMID: 33836003; PMCID: PMC8034723. 10: Serafin V, Capuzzo G, Milani G, Minuzzo SA, Pinazza M, Bortolozzi R, Bresolin S, Porcù E, Frasson C, Indraccolo S, Basso G, Accordi B. Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia. Blood. 2017 Dec 21;130(25):2750-2761. doi: 10.1182/blood-2017-05-784603. Epub 2017 Nov 3. PMID: 29101238.